Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Determinants of the pace of global innovation in energy technologies.

Bettencourt LM, Trancik JE, Kaur J.

PLoS One. 2013 Oct 14;8(10):e67864. doi: 10.1371/journal.pone.0067864. eCollection 2013.

2.

Global assessment of technological innovation for climate change adaptation and mitigation in developing world.

Adenle AA, Azadi H, Arbiol J.

J Environ Manage. 2015 Sep 15;161:261-75. doi: 10.1016/j.jenvman.2015.05.040. Epub 2015 Jul 17.

PMID:
26189184
3.

A review of the health and economic implications of patent protection, with a specific focus on Thailand.

Yamabhai I, Smith RD.

Health Res Policy Syst. 2012 Aug 1;10:24. doi: 10.1186/1478-4505-10-24. Review.

4.

Global unbalance in seaweed production, research effort and biotechnology markets.

Mazarrasa I, Olsen YS, Mayol E, Marbà N, Duarte CM.

Biotechnol Adv. 2014 Sep-Oct;32(5):1028-36. doi: 10.1016/j.biotechadv.2014.05.002. Epub 2014 May 20. Review.

PMID:
24858315
5.

Stimulating investment in energy materials and technologies to combat climate change: an overview of learning curve analysis and niche market support.

Foxon TJ.

Philos Trans A Math Phys Eng Sci. 2010 Jul 28;368(1923):3469-83. doi: 10.1098/rsta.2010.0106. Review.

6.

Innovation in medical technology: reading the indicators.

Littell CL.

Health Aff (Millwood). 1994 Summer;13(3):226-35.

7.

A patent survey case: how could technological forecasting help cosmetic chemists with product innovation?

Domicio Da Silva Souza I, Juliana Pinheiro B, Passarini Takahashi V.

J Cosmet Sci. 2012 Nov-Dec;63(6):365-83.

PMID:
23286869
8.

Renewable energy and sustainable communities: Alaska's wind generator experience.

Konkel RS.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21520. eCollection 2013. Review.

9.

Should financial incentives be used to differentially reward 'me-too' and innovative drugs?

Pekarsky B.

Pharmacoeconomics. 2010;28(1):1-17. doi: 10.2165/11318770-000000000-00000. Review.

PMID:
20014872
10.

Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.

Vasconcellos AG, Morel CM.

PLoS One. 2012;7(10):e45569. doi: 10.1371/journal.pone.0045569. Epub 2012 Oct 3.

11.

Ownership of knowledge--the role of patents in pharmaceutical R&D.

Correa CM.

Bull World Health Organ. 2004 Oct;82(10):784-7; discussion 787-90.

12.

An exploratory investigation of barriers and enablers affecting investment in renewable companies and technologies in the UK.

Wells V, Greenwell F, Covey J, Rosenthal HE, Adcock M, Gregory-Smith D.

Interface Focus. 2013 Feb 6;3(1):20120039. doi: 10.1098/rsfs.2012.0039.

13.

Patenting and licensing in genetic testing.

ESHG Working Party on Patenting and Licensing.

Eur J Hum Genet. 2008 Apr;16(4):405-11. doi: 10.1038/sj.ejhg.5201929. Erratum in: Eur J Hum Genet. 2008 Sep;16(9):1159. Aymé, S [removed]; Matthijs, G [removed]; Soini, S [removed].

14.

The Brazilian investment in science and technology.

Pinheiro-Machado R, De Oliveira PL.

Braz J Med Biol Res. 2001 Dec;34(12):1521-30.

15.

Perspectives on stimulating industrial research and development for neglected infectious diseases.

Webber D, Kremer M.

Bull World Health Organ. 2001;79(8):735-41. Epub 2001 Oct 24.

17.

Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.

Aymé S, Matthijs G, Soini S; ESHG Working Party on Patenting and Licensing.

Eur J Hum Genet. 2008 May;16 Suppl 1:S10-9. doi: 10.1038/ejhg.2008.37.

18.

How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.

Germann PG, Schuhmacher A, Harrison J, Law R, Haug K, Wong G.

Hum Genomics. 2013 Mar 5;7:5. doi: 10.1186/1479-7364-7-5.

19.

Analysis of technological innovation and environmental performance improvement in aviation sector.

Lee J, Mo J.

Int J Environ Res Public Health. 2011 Sep;8(9):3777-95. doi: 10.3390/ijerph8093777. Epub 2011 Sep 22.

20.

Origins of medical innovation: the case of coronary artery stents.

Xu S, Avorn J, Kesselheim AS.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):743-9. doi: 10.1161/CIRCOUTCOMES.112.967398. Epub 2012 Oct 23. Review.

Items per page

Supplemental Content

Write to the Help Desk